{"id":87149,"date":"2023-11-23T18:33:53","date_gmt":"2023-11-23T18:33:53","guid":{"rendered":"https:\/\/www.atlasrleye.com\/proliferative-diabetic-retinopathy-in-type-1-diabetes\/clinical-case-10\/"},"modified":"2024-02-19T01:01:46","modified_gmt":"2024-02-19T01:01:46","slug":"clinical-case-10","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/proliferative-diabetic-retinopathy-in-type-1-diabetes\/clinical-case-10\/","title":{"rendered":"Clinical Case 10"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”DIABETIC RETINOPATHY” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Diabetic%20Retinopathy|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Proliferative Diabetic Retinopathy in Type 1 Diabetes – Clinical Case 10″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fproliferative-diabetic-retinopathy-in-type-1-diabetes%2F|title:PROLIFERATIVE%20DIABETIC%20RETINOPATHY%20IN%20TYPE%201%20DIABETES|”]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\"\"Fluorescein angiography (ultra-widefield) of proliferative diabetic retinopathy in a 48-year-old female patient with the diagnosis of diabetes since 17 years ago. HbA1c=7%. Visual acuity: 20\/28 RE. She refers several hemovitreous and laser therapy. Note large areas of retinal ischemia.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”61988″ img_size=”270×270″ alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

Ultra-widefield photograph 1 day after cataract surgery, vitrectomy and laser therapy.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluations
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=”99″ no_fill=”true” collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”1st Evaluation – 09 07 2013″ tab_id=”1671731979894-a1c6e53a-7f91″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n

\n

Large areas of retinal ischemia.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61949,61907,61901,61964,61946,61943″ img_size=”185×206″ css=”.vc_custom_1708304164794{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”3\/6″][vc_column_text]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61955,61952″ img_size=”282×206″][\/vc_column_inner][vc_column_inner width=”2\/6″][vc_column_text]<\/p>\n

\n
\n

Microperimetry<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61940″ img_size=”287*206″][\/vc_column_inner][vc_column_inner width=”1\/6″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61913″ img_size=”185×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

Neovascularization, microaneurysms and retinal ischemia.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61961,61958,61904,61910″ img_size=”251×206″ css=”.vc_custom_1708304138356{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”2nd Evaluation – postoperative – 11 07 2013″ tab_id=”1671799027455-71491de7-7932″][vc_row_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61970″ img_size=”185×206″][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61967″ img_size=”282×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61976,61973,61979,61982″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

One day after cataract surgery, vitrectomy and laser therapy.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61988,61985″ img_size=”251×206″ css=”.vc_custom_1708304192053{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”3rd Evaluation – 18 07 2013″ tab_id=”1671802470918-9da84a7f-2b3d”][vc_row_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62009,62006″ img_size=”185×206″][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62015″ img_size=”282×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”61997,62000,61994,62003″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/p>\n

\n

One week after surgery and intraocular injection of bevacizumab.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”62018,62012,61991″ img_size=”251×206″ css=”.vc_custom_1708304215374{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”DIABETIC RETINOPATHY” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Diabetic%20Retinopathy|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Proliferative Diabetic Retinopathy in Type 1 Diabetes – Clinical Case 10″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fproliferative-diabetic-retinopathy-in-type-1-diabetes%2F|title:PROLIFERATIVE%20DIABETIC%20RETINOPATHY%20IN%20TYPE%201%20DIABETES|”][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner][vc_column_text] Fluorescein angiography (ultra-widefield) of […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":75353,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-87149","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/87149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/comments?post=87149"}],"version-history":[{"count":7,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/87149\/revisions"}],"predecessor-version":[{"id":97192,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/87149\/revisions\/97192"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75353"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/media?parent=87149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}